US Broker Ratings

Zai Lab Limited (ZLAB) Stock Analysis: Potential 161% Upside Amid Strong Buy Consensus

Zai Lab Limited (NASDAQ: ZLAB) presents a compelling opportunity for investors seeking exposure to the rapidly evolving biotechnology sector. With a solid market capitalization of $2.04..

Biohaven Ltd. (BHVN) Investor Outlook: Navigating Opportunities with a 68% Upside Potential

Biohaven Ltd. (NASDAQ: BHVN), a prominent player in the biotechnology industry, has been capturing investor attention with its innovative approach in developing therapies across immunology, neuroscience,..

Organon & Co. (OGN) Stock Analysis: Exploring a 15% Potential Upside Amidst Diverse Product Portfolio

Organon & Co. (OGN), a prominent player in the healthcare sector, operates within the drug manufacturing industry, offering a wide range of health solutions through prescription..

Edgewise Therapeutics (EWTX) Stock Analysis: A 58% Upside Potential in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a burgeoning player in the biotechnology industry, has captured investor attention with an enticing potential upside of 58.17%. This biopharmaceutical company,..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Innovator with a 13% Potential Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK), a Cambridge-based biopharmaceutical company, is making headlines with its innovative approach in the biotechnology sector. Focusing on the discovery and..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating a Path with a 20% Upside Potential

Tandem Diabetes Care, Inc. (TNDM) stands as a significant player in the healthcare sector, specifically within the medical devices industry. Headquartered in San Diego, California, Tandem..

Sotera Health Company (SHC) Stock Analysis: Strong Buy Ratings and 7.68% Potential Upside

Sotera Health Company (NASDAQ: SHC) is drawing attention from investors with a strong buy consensus and a promising potential upside. As a leading player in the..

CONMED Corporation (CNMD) Stock Analysis: A Look at Healthcare’s Undervalued Player with 11% Upside Potential

CONMED Corporation (NASDAQ: CNMD), a key player in the medical devices sector, stands as an intriguing prospect for investors seeking exposure in the healthcare industry. With..

Envista Holdings Corporation (NVST) Stock Analysis: A Healthcare Player with a Mixed Growth Outlook

Envista Holdings Corporation (NYSE: NVST) is an intriguing entity in the healthcare sector, focusing on the medical instruments and supplies industry. As of the latest data,..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Evaluating a 10.28% Potential Upside for Investors

Guardian Pharmacy Services, Inc. (GRDN), a pivotal player in the healthcare sector, specifically within the medical care facilities industry, is capturing the attention of investors with..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Strong Growth, Attractive Valuation, and Promising Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a prominent player in the biotechnology sector, is catching the eye of investors with its robust growth trajectory and promising..

GeneDx Holdings Corp. (WGS) Stock Analysis: Evaluating the 43.32% Potential Upside in the Genomic Sector

GeneDx Holdings Corp. (NASDAQ: WGS) stands at the intersection of cutting-edge genomics and diagnostics, carving a niche in the healthcare industry with its pioneering genetic testing..

Select Medical Holdings Corp (SEM): Investor Outlook with 21.45% Potential Upside

Select Medical Holdings Corp (NYSE: SEM) is making waves in the healthcare sector, particularly in the medical care facilities industry. Based in the United States, this..

Enovis Corporation (ENOV) Stock Analysis: Exploring the 68.66% Potential Upside for This Medical Device Innovator

Enovis Corporation (NYSE: ENOV) is making waves in the healthcare sector, particularly in the medical devices industry. With a market capitalization of $1.54 billion, this Wilmington,..

Progyny, Inc. (PGNY) Stock Analysis: Analyst Consensus and Growth Potential in the Fertility Benefits Sector

Progyny, Inc. (NASDAQ: PGNY), a prominent player in the healthcare sector, is gaining substantial attention from investors, thanks largely to its innovative approach to fertility and..

Twist Bioscience Corporation (TWST): Investor Outlook Reveals 16.9% Revenue Growth and Bullish Analyst Ratings

Twist Bioscience Corporation (NASDAQ: TWST), a pioneering entity in the healthcare sector focused on diagnostics and research, has captured investor attention with its robust revenue growth..

BGM Group Ltd. (BGM): Navigating the Challenges in the Healthcare Sector

BGM Group Ltd. (BGM), a prominent player in the healthcare sector, operates within the specialized and generic drug manufacturing industry in China. Despite its significant market..

Vericel Corporation (VCEL) Stock Analysis: Unveiling a 50% Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, has recently caught the attention of investors due to its promising potential upside of 50.31%,..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech with 46% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is capturing investor attention with its promising pipeline and substantial upside potential. As a late-stage biopharmaceutical company based in Naarden,..

Concentra Group Holdings Parent (CON): Investor Outlook on 38% Potential Upside

Concentra Group Holdings Parent, Inc. (CON) is gaining significant attention from investors, particularly those interested in the healthcare sector. As a provider of essential occupational health..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds